Cargando…
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450768/ https://www.ncbi.nlm.nih.gov/pubmed/34552950 http://dx.doi.org/10.3389/fmed.2021.743325 |
| _version_ | 1784569718369157120 |
|---|---|
| author | Alape-Girón, Alberto Moreira-Soto, Andrés Arguedas, Mauricio Brenes, Hebleen Buján, Willem Corrales-Aguilar, Eugenia Díaz, Cecilia Echeverri, Ann Flores-Díaz, Marietta Gómez, Aarón Hernández, Andrés Herrera, María León, Guillermo Macaya, Román Molina-Mora, José Arturo Mora, Javier Narayanan, Aarthi Sanabria, Alfredo Sánchez, Andrés Sánchez, Laura Segura, Álvaro Segura, Eduardo Solano, Daniela Soto, Claudio Stynoski, Jennifer L. Vargas, Mariángela Villalta, Mauren Drexler, Jan Felix Gutiérrez, José María |
| author_facet | Alape-Girón, Alberto Moreira-Soto, Andrés Arguedas, Mauricio Brenes, Hebleen Buján, Willem Corrales-Aguilar, Eugenia Díaz, Cecilia Echeverri, Ann Flores-Díaz, Marietta Gómez, Aarón Hernández, Andrés Herrera, María León, Guillermo Macaya, Román Molina-Mora, José Arturo Mora, Javier Narayanan, Aarthi Sanabria, Alfredo Sánchez, Andrés Sánchez, Laura Segura, Álvaro Segura, Eduardo Solano, Daniela Soto, Claudio Stynoski, Jennifer L. Vargas, Mariángela Villalta, Mauren Drexler, Jan Felix Gutiérrez, José María |
| author_sort | Alape-Girón, Alberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8450768 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84507682021-09-21 Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 Alape-Girón, Alberto Moreira-Soto, Andrés Arguedas, Mauricio Brenes, Hebleen Buján, Willem Corrales-Aguilar, Eugenia Díaz, Cecilia Echeverri, Ann Flores-Díaz, Marietta Gómez, Aarón Hernández, Andrés Herrera, María León, Guillermo Macaya, Román Molina-Mora, José Arturo Mora, Javier Narayanan, Aarthi Sanabria, Alfredo Sánchez, Andrés Sánchez, Laura Segura, Álvaro Segura, Eduardo Solano, Daniela Soto, Claudio Stynoski, Jennifer L. Vargas, Mariángela Villalta, Mauren Drexler, Jan Felix Gutiérrez, José María Front Med (Lausanne) Medicine Frontiers Media S.A. 2021-09-06 /pmc/articles/PMC8450768/ /pubmed/34552950 http://dx.doi.org/10.3389/fmed.2021.743325 Text en Copyright © 2021 Alape-Girón, Moreira-Soto, Arguedas, Brenes, Buján, Corrales-Aguilar, Díaz, Echeverri, Flores-Díaz, Gómez, Hernández, Herrera, León, Macaya, Molina-Mora, Mora, Narayanan, Sanabria, Sánchez, Sánchez, Segura, Segura, Solano, Soto, Stynoski, Vargas, Villalta, Drexler and Gutiérrez. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Alape-Girón, Alberto Moreira-Soto, Andrés Arguedas, Mauricio Brenes, Hebleen Buján, Willem Corrales-Aguilar, Eugenia Díaz, Cecilia Echeverri, Ann Flores-Díaz, Marietta Gómez, Aarón Hernández, Andrés Herrera, María León, Guillermo Macaya, Román Molina-Mora, José Arturo Mora, Javier Narayanan, Aarthi Sanabria, Alfredo Sánchez, Andrés Sánchez, Laura Segura, Álvaro Segura, Eduardo Solano, Daniela Soto, Claudio Stynoski, Jennifer L. Vargas, Mariángela Villalta, Mauren Drexler, Jan Felix Gutiérrez, José María Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title | Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title_full | Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title_fullStr | Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title_full_unstemmed | Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title_short | Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19 |
| title_sort | heterologous hyperimmune polyclonal antibodies against sars-cov-2: a broad coverage, affordable, and scalable potential immunotherapy for covid-19 |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450768/ https://www.ncbi.nlm.nih.gov/pubmed/34552950 http://dx.doi.org/10.3389/fmed.2021.743325 |
| work_keys_str_mv | AT alapegironalberto heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT moreirasotoandres heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT arguedasmauricio heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT breneshebleen heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT bujanwillem heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT corralesaguilareugenia heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT diazcecilia heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT echeverriann heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT floresdiazmarietta heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT gomezaaron heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT hernandezandres heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT herreramaria heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT leonguillermo heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT macayaroman heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT molinamorajosearturo heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT morajavier heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT narayananaarthi heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT sanabriaalfredo heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT sanchezandres heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT sanchezlaura heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT seguraalvaro heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT seguraeduardo heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT solanodaniela heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT sotoclaudio heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT stynoskijenniferl heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT vargasmariangela heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT villaltamauren heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT drexlerjanfelix heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 AT gutierrezjosemaria heterologoushyperimmunepolyclonalantibodiesagainstsarscov2abroadcoverageaffordableandscalablepotentialimmunotherapyforcovid19 |